Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.
about
An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension.Aliskiren - an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertensionRenin and cardiovascular disease: Worn-out path, or new direction.First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination.Aliskiren, amlodipine and hydrochlorothiazide triple combination for hypertensionUnmet needs in managing hypertension: potential role of direct renin inhibition.Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment.The role of direct renin inhibition in clinical practice: focus on combination therapy.The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.Direct renin inhibition: extricating facts from façades.Renin Inhibition with Aliskiren: A Decade of Clinical Experience.Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control.
P2860
Q33906856-504A95A1-ABFC-471E-A637-37A7E357BFF5Q34247173-F3A14828-F294-4C32-BFB5-25EAD2027F5AQ34801804-1F58A3AB-76A4-4184-8DD4-84DB0409F67DQ35210508-F3AD3C6F-F384-4607-BCB0-03C95414160CQ37125703-8510C0D1-7997-4ECF-A643-0F2D07126C9EQ37750291-966FD462-1AF0-474A-A702-4E16EF9ED622Q37812140-7380E5EC-B277-443F-82DB-46F72871BA7FQ37918526-3D1E82E3-0C63-44AC-8D59-F17CCC6BA436Q37980260-0B5128A4-772E-43FB-8CE5-9FAF96075824Q38088975-5BC872E9-F03B-4FC5-85A5-E6643000FAF8Q38672900-E36483F6-1B27-42BB-A14C-1E95695FB894Q51579351-F073528B-6619-4AAD-B9A8-6A7E2C9CDFA0
P2860
Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@ast
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@en
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@nl
type
label
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@ast
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@en
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@nl
prefLabel
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@ast
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@en
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@nl
P2093
P1433
P1476
Aliskiren monotherapy does not ...... f data from 8 clinical trials.
@en
P2093
Alan H Gradman
Juerg Nussberger
Margaret F Prescott
Ramesh Sarangapani
Roland E Schmieder
P356
10.1161/HYPERTENSIONAHA.109.135772
P407
P577
2009-11-16T00:00:00Z